Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - vancomycin, quantity: 1 g (equivalent: vancomycin, qty 1 million iu) - injection, powder for - excipient ingredients: disodium edetate; sodium hydroxide; hydrochloric acid - indicated for potentially life-threatening infections which cannot be treated with another effective, less toxic antimicrobial drug, including the penicillins and cephalosporins. severe staphylococcal (including methicillin-resistant staphylococcal) infections in patients who cannot receive or who failed to respond to the penicillins and cephalosporins or who have infections with staphylococci that are resistant to other antibiotics. once sensitivity data are available, therapy should be adjusted accordingly. alone or in combination with an aminoglycoside for endocarditis caused by s. viridans or s. bovis. for endocarditis caused by enterococci (eg e faecalis), only in combination with an aminoglycoside. for the treatment of diphtheroid endocarditis. in combination with rifampin, an aminoglycoside or both in early-onset prosthetic valve endocarditis caused by s. epidermidis or diphtheroids. in other infections due to staphylococci including osteomyelitis, pneumonia, septicaemia, and soft tissue infections. wh

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - vancomycin, quantity: 500 mg (equivalent: vancomycin, qty 500000 iu) - injection, powder for - excipient ingredients: disodium edetate; hydrochloric acid; sodium hydroxide - indicated for potentially life-threatening infections which cannot be treated with another effective, less toxic antimicrobial drug, including the penicillins and cephalosporins. severe staphylococcal (including methicillin-resistant staphylococcal) infections in patients who cannot receive or who failed to respond to the penicillins and cephalosporins or who have infections with staphylococci that are resistant to other antibiotics. once sensitivity data are available, therapy should be adjusted accordingly. alone or in combination with an aminoglycoside for endocarditis caused by s. viridans or s. bovis. for endocarditis caused by enterococci (eg e faecalis), only in combination with an aminoglycoside. for the treatment of diphtheroid endocarditis. in combination with rifampin, an aminoglycoside or both in early-onset prosthetic valve endocarditis caused by s. epidermidis or diphtheroids. in other infections due to staphylococci including osteomyelitis, pneumonia, septicaemia, and soft tissue infections. wh

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - teicoplanin, quantity: 400 mg - injection, powder for - excipient ingredients: sodium chloride - targocid is indicated for the treatment of the following infections due to staphylococci or streptococci, which cannot be treated satisfactorily with less toxic agents, including b-lactam antibiotics: - bone - osteomyelitis; joints - septic arthritis; blood - non-cardiac bacteraemia, septicaemia.

Philippines - English - FDA (Food And Drug Administration)

glaxosmithkline philippines, inc. - vancomycin (as hydrochloride) - powder for injection (iv) - 500mg

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - teicoplanin 100mg;   - powder for injection with diluent - 100 mg - active: teicoplanin 100mg   excipient: sodium chloride sodium hydroxide water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - teicoplanin 200mg;   - powder for injection with diluent - 200 mg - active: teicoplanin 200mg   excipient: sodium chloride sodium hydroxide water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - teicoplanin 400mg - powder for injection with diluent - 400 mg - active: teicoplanin 400mg excipient: sodium chloride sodium hydroxide water for injection

Ireland - English - HPRA (Health Products Regulatory Authority)

flynn pharma limited - vancomycin - powder for concentrate for solution for infusion - 500 milligram(s) - glycopeptide antibacterials; vancomycin

Ireland - English - HPRA (Health Products Regulatory Authority)

flynn pharma limited - vancomycin - powder for concentrate for solution for infusion - 1 gram(s) - glycopeptide antibacterials; vancomycin

Canada - English - Health Canada

fresenius kabi canada ltd - vancomycin (vancomycin hydrochloride) - powder for solution - 500mg - vancomycin (vancomycin hydrochloride) 500mg - glycopeptides